Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX offers sermorelin alongside semaglutide, tirzepatide, NAD+ therapy, and berberine as part of a comprehensive clinical platform. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🧬 What is sermorelin and why are GLP-1 patients using it? In this episode of TelehealthFX Talk, we explain how sermorelin works at the cellular level, how it differs from synthetic HGH, what the evidence actually supports, and why it is one of the most effective tools for preserving lean muscle mass during GLP-1 weight loss.

👇 HERE'S WHAT WE COVER 👇

• What is sermorelin? — a synthetic analog of growth hormone-releasing hormone (GHRH). Stimulates the pituitary gland to produce and release the body's OWN growth hormone. Works "upstream" through natural signaling, preserving the body's feedback loops and pulsatile GH release pattern. Administered via nightly subcutaneous injection (typically 100-300 mcg).

• Sermorelin vs. synthetic HGH — critical difference:

  - Sermorelin: stimulates YOUR body to make more GH naturally

  - HGH: directly injects manufactured growth hormone, bypasses pituitary, can suppress natural production

  - Sermorelin: preserves natural feedback loops, milder side effects

  - HGH: higher risk of joint pain, edema, insulin resistance, carpal tunnel

• Growth hormone decline ("somatopause") — GH production naturally declines starting in the 30s. Associated with decreased muscle mass, increased body fat, reduced energy, poorer sleep, slower recovery. Sermorelin aims to restore more youthful GH production patterns.

• How sermorelin complements GLP-1:

  - GLP-1 creates caloric deficit → drives weight loss

  - Risk: some weight loss comes from muscle (covered in EP02)

  - Sermorelin supports lean mass preservation by boosting natural GH

  - GH plays roles in protein synthesis, tissue repair, fat metabolism

  - The 4-part system: GLP-1 + sermorelin + NAD+ + resistance training = fat loss with muscle preservation

• Reported benefits (with honest assessment):

  - Body composition: may improve lean mass and fat metabolism (modest, variable results in studies)

  - Recovery: may support faster workout recovery through tissue repair

  - Sleep: some patients report deeper sleep (limited clinical consensus)

  - Energy: commonly reported over weeks of use

  - NOT a standalone weight loss or anti-aging treatment

• Important honesty:

  - Not FDA-approved for anti-aging or weight loss in adults

  - Off-label use through compounding pharmacies

  - Clinical evidence for anti-aging is not robust

  - Long-term safety data is limited

  - Requires medical supervision and IGF-1 monitoring

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: The muscle preservation problem

1:00 — What is sermorelin? GHRH explained

2:00 — Sermorelin vs. synthetic HGH: critical difference

3:00 — Natural feedback loops and safety

3:45 — Growth hormone decline after 30

4:15 — How sermorelin complements GLP-1

5:00 — Reported benefits: body comp, recovery, sleep, energy

5:45 — Honest assessment: what is proven vs. emerging

6:30 — The 4-part system: GLP-1 + sermorelin + NAD+ + exercise

7:15 — TelehealthFX's comprehensive platform

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

TelehealthFX offers sermorelin as part of a comprehensive platform with GLP-1, NAD+, and berberine. Licensed clinicians evaluate which combination is right for you. 24-hour provider review. 1-on-1 onboarding. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone on GLP-1 who is concerned about losing muscle during weight loss. Anyone curious about peptide therapy and wanting honest information. Anyone interested in body composition optimization, not just weight loss. Anyone comparing sermorelin to HGH and wanting to understand the difference.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, peptide therapy, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. Sermorelin is a prescription medication not FDA-approved for anti-aging or weight loss. Always consult your healthcare provider and ensure proper monitoring while using peptide therapy. Individual results vary.

#Sermorelin #PeptideTherapy #GrowthHormone #GHRH #LeanMass #MusclePreservation #GLP1 #Semaglutide #Tirzepatide #WeightLoss #BodyComposition #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #AntiAging #HGHAlternative #NADTherapy #NoHiddenFees #FatLoss #MuscleGain #GLP1WeightLoss #WeightLossProgram #PeptideScience #Somatopause

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX provides comprehensive clinical support that includes your emotional relationship with food and mental well-being, not just weight. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🧠 What does GLP-1 do to your mental health? In this episode of TelehealthFX Talk, we break down "food noise" and why silencing it is the most life-changing part of the GLP-1 experience, cover the positive mental health effects patients report, address the FDA suicidality investigation head-on with the final ruling, and discuss the emotional nuances of weight loss that nobody talks about.

👇 HERE'S WHAT WE COVER 👇

• What is food noise? — constant, intrusive, obsessive thoughts about food regardless of physical hunger. Persistent mental chatter: fixating on the next meal, overwhelming cravings, compulsive snacking urges. Not a formal diagnosis but widely recognized. Makes it difficult to focus, creates shame and anxiety, drives emotional eating and binge eating patterns.

• How GLP-1 silences food noise — modulates dopamine reward pathways making hyperpalatable foods less compelling. Slows gastric emptying and signals fullness. Patients describe "mental silence." Survey data: constant food thoughts declined ~46% on semaglutide. Allows intentional eating choices instead of reactive impulses.

• Positive mental health effects reported by patients:

  - Reduced food-related anxiety

  - Improved self-esteem from body changes

  - Better sleep from weight loss

  - More social confidence

  - Reduced emotional eating

  - The mental transformation patients call "life-changing"

• The suicidality investigation — FULLY CLEARED:

  - 2023: reports trigger FDA/EMA investigations

  - April 2024: EMA concludes NO causal association

  - Jan 13, 2026: FDA concludes NO increased risk (meta-analysis of 91 trials, 107,000+ patients; Sentinel System study of 2.2M users)

  - FDA requested REMOVAL of suicidal ideation warnings from product labels

  - Both US and European regulators cleared GLP-1 medications

• Important nuance — emotional adjustment:

  - Food is a coping mechanism for many people (stress, anxiety, loneliness)

  - When medication removes food compulsion, underlying emotions can surface

  - This is NOT a medication side effect — it is uncovering masked emotions

  - Represents an opportunity for growth with proper support

  - Therapy, counseling, and comprehensive clinical programs are critical

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: The most emotional episode

1:00 — What is food noise?

2:00 — How food noise impacts daily life

2:45 — How GLP-1 silences food noise (46% reduction)

3:30 — The mental transformation: anxiety, self-esteem, sleep

4:15 — Addressing the suicidality investigation

5:00 — FDA/EMA final rulings: CLEARED

5:45 — Emotional adjustment: when food was your coping mechanism

6:30 — Why comprehensive support matters

7:15 — TelehealthFX: seeing the whole picture

7:45 — Visit TelehealthFX

🆘 CRISIS RESOURCES 🆘

If you or someone you know is experiencing thoughts of self-harm, please contact:

• 988 Suicide and Crisis Lifeline: Call or text 988

• Crisis Text Line: Text HOME to 741741

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

TelehealthFX understands weight loss is a psychological journey as much as physical. 1-on-1 onboarding includes emotional relationship with food and mental health. Licensed clinicians who see the whole picture. Semaglutide, tirzepatide, NAD+, sermorelin, berberine. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone experiencing constant thoughts about food who wants to understand food noise. Anyone worried about mental health side effects of GLP-1 medications. Anyone on GLP-1 who is experiencing emotional changes during their weight loss journey. Anyone who uses food as a coping mechanism and wants to understand what happens when that changes.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, mental health, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. GLP-1 medications are not approved for the treatment of mental health conditions. If you are experiencing depression, anxiety, or thoughts of self-harm, please reach out to a mental health professional. Individual results vary.

#FoodNoise #GLP1MentalHealth #OzempicMentalHealth #FoodNoiseGLP1 #GLP1 #Semaglutide #Tirzepatide #WeightLoss #MentalHealth #EmotionalEating #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #FDACleared #SuicidalityRuling #AnxietyAndFood #DepressionAndWeight #BingeEating #OzempicAlternative #NoHiddenFees #NADTherapy #WeightLossJourney #MentalWellness #FoodRelationship #WeightLossProgram

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX is a transparent, clinically supervised program with licensed providers and proper medication handling. No shady compounding workarounds. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🛡️ Is your compounded semaglutide actually safe? In this episode of TelehealthFX Talk, we break down everything that has changed with the FDA's crackdown on compounded GLP-1 medications, the real documented safety risks, and exactly how to protect yourself. If you are using or considering a compounded product, this episode is essential listening.

👇 HERE'S WHAT WE COVER 👇

• The regulatory timeline:

  - Pre-Feb 2025: semaglutide on FDA shortage list → compounding legally permitted

  - Feb 21, 2025: FDA declares shortage RESOLVED

  - April 22, 2025: 503A pharmacy grace period ends (60 days)

  - May 22, 2025: 503B outsourcing facility grace period ends (90 days)

  - April 2026: FDA proposes removing semaglutide, tirzepatide, liraglutide from 503B bulks list entirely

  - May 2026: enforcement discretion period has ended

• 503A vs. 503B explained — 503A pharmacies compound per individual prescription. 503B outsourcing facilities produce larger batches under CGMP standards. Both could only legally compound copies of FDA-approved drugs during shortages.

• FDA-documented safety concerns:

  - No pre-market review — compounded drugs skip FDA safety, efficacy, and quality testing

  - Hundreds of adverse event reports, including hospitalizations

  - Dosing errors from non-standardized concentrations

  - Sterility and contamination issues found during inspections

  - Fraudulent products labeled "research grade" or "not for human consumption"

  - Semaglutide sodium vs. semaglutide base — different chemical forms, different safety profiles

  - Cold chain failures — products arriving without proper refrigeration

• How to verify a pharmacy (consumer protection checklist):

  - Must require a valid prescription from a licensed provider

  - Must be state Board of Pharmacy licensed (verify via state website or APC "Is It Legit?" tool)

  - Should have PCAB accreditation (Pharmacy Compounding Accreditation Board)

  - Should test for sterility and potency via independent third-party labs

  - Should provide Certificate of Analysis (COA) for active ingredients

  - Must have a verifiable physical US address and phone number

• Red flags to watch for:

  - No prescription required

  - Claims to sell "Compounded Ozempic" or "Compounded Wegovy" (brand name misuse)

  - Prices that seem too good to be true

  - "For research purposes only" labels

  - No verifiable physical address

  - Products arriving warm without cold chain packaging

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: This episode could save you

1:00 — Regulatory timeline: shortage resolved Feb 2025

2:00 — 503A vs. 503B pharmacies explained

2:45 — FDA enforcement: grace periods ended

3:15 — Safety concern #1: no pre-market review

3:45 — Safety concerns #2-4: adverse events, dosing, sterility

4:30 — Semaglutide sodium vs. semaglutide base

5:00 — Red flags and fraudulent products

5:30 — Consumer protection checklist

6:30 — The TelehealthFX difference

7:15 — "Your health is too important for shortcuts"

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

In a landscape full of questionable compounders, TelehealthFX is the transparent, clinically supervised alternative. Licensed providers. 24-hour provider review. 1-on-1 onboarding. Semaglutide, tirzepatide, NAD+, sermorelin, berberine. Transparent pricing. No hidden fees. 2-day UPS shipping with proper handling. All 50 states.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone currently using compounded semaglutide who wants to understand the current risks and regulations. Anyone considering a cheaper compounded alternative and wanting honest information. Healthcare providers and patients navigating the post-shortage regulatory landscape. Anyone who wants to verify whether their pharmacy is legitimate.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 safety, consumer protection, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical or legal advice. The regulatory landscape around compounding is complex and evolving. Always ensure your medications come from verified, licensed sources. Consult your healthcare provider with any concerns. Individual results vary.

#CompoundedSemaglutide #IsSemaglutideSafe #FDACompounding #GLP1Safety #Semaglutide #Tirzepatide #CompoundingPharmacy #FDACrackdown #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #ConsumerProtection #OzempicAlternative #WeightLoss #NoHiddenFees #503A #503B #DrugSafety #GLP1 #MedicationSafety #WeightLossProgram #PatientSafety #FDAApproved

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX offers NAD+ therapy alongside semaglutide, tirzepatide, and sermorelin as part of a comprehensive clinical platform. No hidden membership fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🧬 What does NAD+ therapy actually do? Is it really an anti-aging breakthrough, or is the marketing ahead of the science? In this episode of TelehealthFX Talk, we give you the completely honest, research-based answer. We break down what NAD+ is, how it works at the cellular level, what human clinical trials actually show, and why it makes sense as a complement to GLP-1 weight loss — without the hype.

👇 HERE'S WHAT WE COVER 👇

• What is NAD+? — Nicotinamide adenine dinucleotide, a coenzyme in every living cell. Essential for three critical processes: energy production (mitochondrial ATP generation), DNA repair (PARP enzymes), and sirtuin activation (longevity gene regulators SIRT1-SIRT7).

• The age-related decline — NAD+ levels drop significantly with age, potentially halving by middle age. Less NAD+ → less sirtuin activity → less mitochondrial function → less energy, more cellular damage, faster aging. This is considered a fundamental driver of age-related decline.

• The NAD+-sirtuin-mitochondria axis — sirtuins are NAD+-dependent "longevity regulators" controlling gene expression for stress resistance, inflammation, and metabolic efficiency. When NAD+ drops, sirtuins cannot function and mitochondria decline.

• What the research actually supports:

  - NMN and NR precursors reliably raise blood NAD+ levels (multiple human RCTs)

  - Some evidence for improved muscle insulin sensitivity

  - Some evidence for improved physical function in older adults

  - Preclinical data shows improved mitochondrial efficiency

• What is honest but important to acknowledge:

  - No definitive evidence NAD+ extends human lifespan

  - NAD+ is NOT a direct weight loss agent

  - Brain fog, addiction recovery, "reversing aging" claims lack large-scale RCT support

  - Long-term human data is still limited

• Why NAD+ complements GLP-1 — weight loss creates significant metabolic transition and cellular stress. NAD+ supports cells during this transition: energy production, DNA repair, sirtuin activation. Especially relevant for patients over 40 where NAD+ decline is most pronounced. "NAD+ is not the engine of weight loss. It is the oil that keeps the engine running."

• Delivery methods explained:

  - Oral precursors (NMN/NR): most studied, 250-1,000mg/day, safe, affordable

  - Injectable/subcutaneous: higher bioavailability, clinical dosing

  - IV infusions: limited clinical data, often uncomfortable, most expensive

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: NAD+ — hype vs. science

1:15 — What is NAD+? The cellular workhorse

2:15 — Three critical roles: energy, DNA repair, sirtuins

3:00 — The age-related decline and why it matters

3:45 — What human clinical trials actually show

4:45 — Honest assessment: what is NOT proven yet

5:30 — Why NAD+ complements GLP-1 weight loss

6:15 — Delivery methods: oral vs. injectable vs. IV

7:00 — Comprehensive wellness at TelehealthFX

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

TelehealthFX offers NAD+ as part of a comprehensive clinical platform alongside semaglutide, tirzepatide, sermorelin, and lifestyle guidance. Licensed clinicians evaluate whether NAD+ is appropriate for your situation. 24-hour provider review. 1-on-1 onboarding. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone curious about NAD+ therapy and wants the honest, research-based explanation. Anyone over 40 interested in supporting cellular health during weight loss. Anyone on GLP-1 medications looking for complementary wellness support. Anyone skeptical of NAD+ hype who wants to separate science from marketing.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, longevity, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. NAD+ therapy is not FDA-approved for anti-aging or weight loss. Individuals with a history of cancer should discuss NAD+ supplementation with their oncologist. Always consult your healthcare provider before starting any new therapy. Individual results vary.

#NADTherapy #NADPlus #AntiAging #CellularHealth #Sirtuins #Mitochondria #Longevity #NMN #NicotinamideRiboside #GLP1 #Semaglutide #Tirzepatide #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #WeightLoss #BiohackingScience #NADPlusTherapy #EnergyProduction #DNARepair #HealthyAging #WeightManagement #NoHiddenFees #Sermorelin #ComprehensiveWellness

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — private, clinical, no judgment, from your couch. See if you are eligible for semaglutide or tirzepatide with real clinical support. No hidden membership fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🧔‍♂️ GLP-1 medications are not just for women. In this episode of TelehealthFX Talk, we break down the male-specific health risks of obesity and how weight loss with semaglutide or tirzepatide can improve testosterone, cardiovascular health, erectile function, and sleep apnea. If you have been putting off getting help because you feel like weight loss meds are "not for guys," this episode will change your mind.

👇 HERE'S WHAT WE COVER 👇

• Heart disease — obesity-related heart disease deaths in US men increased 243% between 1999-2020 (AHA). Having obesity for 10+ years increases heart attack/stroke risk by 25-60% in men under 65. Each BMI point increase = ~5% increase in heart failure risk.

• Testosterone and visceral fat — belly fat contains aromatase enzyme that converts testosterone to estrogen. Each BMI point increase → ~2% decrease in testosterone. 4-inch waist increase → 75% increased risk of low testosterone. Up to 40% of obese men experience testosterone deficiency. Symptoms: fatigue, decreased muscle mass, depression, reduced libido.

• Erectile dysfunction — obesity causes endothelial dysfunction (impaired blood flow). Obese men have 30-90% increased risk of ED. 79% of men presenting with ED have BMI ≥25. 42-inch waist = ~2x more likely to develop ED vs. 32-inch waist. ED is often the earliest warning sign of cardiovascular disease.

• Sleep apnea — obesity is the strongest reversible risk factor. ~74% of obese adults have some form of OSA. 10% weight gain → 6x increased risk of moderate-to-severe OSA.

• How GLP-1 addresses male-specific issues:

  - Visceral fat reduction: GLP-1 is particularly effective at reducing abdominal fat men disproportionately carry

  - Testosterone recovery: less visceral fat → less aromatase → less T-to-estrogen conversion → natural T recovery

  - ED improvement: weight loss → better vascular function → improved blood flow

  - Sleep apnea improvement: weight loss → reduced airway compression → many patients reduce/eliminate CPAP

  - Cardiovascular protection: semaglutide has documented CV risk reduction

• Why telehealth works for men — no waiting room, no face-to-face weigh-in, no judgment. Private, convenient, from home on your schedule. Men are more likely to engage with healthcare through telehealth.

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: GLP-1 is not just for women

1:15 — Heart disease: 243% increase in obesity-related deaths

2:15 — Testosterone: how belly fat steals your T

3:15 — Erectile dysfunction: the vascular connection

4:15 — Sleep apnea: obesity's silent threat

5:00 — How GLP-1 addresses all four issues

5:45 — Testosterone recovery through weight loss

6:15 — Why telehealth works for men

7:00 — "Taking action is not weakness — it is strategic"

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

Everything is handled privately. 24-hour provider review by licensed clinicians who evaluate your full health picture. 1-on-1 onboarding. Semaglutide, tirzepatide, NAD+ therapy for energy, and sermorelin for lean mass support. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Men over 30 who have gained weight and noticed declining energy, motivation, or performance. Men experiencing symptoms of low testosterone who want to understand the weight connection. Any man who has been hesitant to seek weight loss help because of stigma. Partners of men who need this information shared with them.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, men's health, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. If you are experiencing symptoms of low testosterone, erectile dysfunction, or sleep apnea, please consult your healthcare provider for proper evaluation. Individual results vary.

#WeightLossForMen #MensHealth #GLP1ForMen #Testosterone #LowTestosterone #VisceralFat #ErectileHealth #SleepApnea #GLP1 #Semaglutide #Tirzepatide #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #MaleObesity #HeartHealth #OzempicAlternative #WeightLossDelivered #NoHiddenFees #NADTherapy #Sermorelin #MensWeightLoss #TestosteroneRecovery #WeightManagement #CardiovascularHealth

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX's 1-on-1 onboarding covers lifestyle factors including alcohol guidance so you are prepared for every change. No hidden membership fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🍷 Can you drink alcohol on Ozempic? Why are people saying GLP-1 medications made them stop drinking? In this episode of TelehealthFX Talk, we break down the real science behind why semaglutide and tirzepatide change your relationship with alcohol, walk through published clinical trial data from JAMA Psychiatry and The Lancet, and cover the critical safety risks that nobody is talking about.

👇 HERE'S WHAT WE COVER 👇

• Why GLP-1 medications reduce alcohol desire — GLP-1 receptors exist in the brain's reward centers (nucleus accumbens, ventral tegmental area). Semaglutide modulates the dopamine pathways that drive alcohol's pleasurable effects, essentially "turning down the volume" on alcohol's reward signal. Same mechanism that reduces "food noise" appears to reduce "alcohol noise." Additionally, slowed gastric emptying delays alcohol absorption, weakening the rapid reward hit.

• Clinical trial evidence:

  - 2025 JAMA Psychiatry trial: weekly semaglutide significantly reduced alcohol cravings, drinks per drinking day, and heavy drinking days

  - 2026 Lancet trial: adults with obesity + alcohol use disorder showed statistically greater decrease in heavy drinking days on semaglutide vs. placebo after 26 weeks

  - Phase 3 trials for addiction-specific applications are underway

  - Important: semaglutide is NOT FDA-approved for alcohol use disorder

• 5 safety risks of drinking on GLP-1:

  - Dramatically lower alcohol tolerance — get intoxicated faster from fewer drinks due to slowed gastric emptying and reduced food intake

  - Worsened GI side effects — alcohol irritates stomach lining, amplifying nausea, vomiting, and diarrhea

  - Blood sugar danger — both alcohol and GLP-1 lower blood sugar. Alcohol inhibits the liver's glucose release. Combined hypoglycemia risk is serious, especially for diabetics

  - Compounded dehydration — alcohol is a diuretic + GLP-1 side effects cause fluid loss = significant dehydration risk

  - Empty calories undermine weight loss goals and lower food choice inhibitions

• Practical guidelines if you choose to drink:

  - Talk to your provider about alcohol use

  - Moderate consumption (1 drink/day women, 2 men)

  - Never drink on an empty stomach

  - Stay hydrated — water between drinks

  - Know your new tolerance — start with far less

  - Monitor for hypoglycemia signs (shakiness, confusion, sweating)

  - Avoid binge drinking — your body handles it very differently now

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: The "Ozempic made me stop drinking" phenomenon

1:15 — GLP-1 receptors in the brain's reward centers

2:15 — Dopamine pathway modulation explained

3:00 — Clinical trials: JAMA Psychiatry 2025 + Lancet 2026

3:45 — NOT FDA-approved for alcohol use disorder

4:00 — Safety risk #1: Dramatically lower tolerance

4:30 — Safety risks #2-3: GI side effects + blood sugar danger

5:15 — Safety risks #4-5: Dehydration + empty calories

5:45 — Practical guidelines for drinking on GLP-1

6:45 — Why clinical support matters

7:15 — "This episode could keep someone safe"

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

TelehealthFX prepares you for the lifestyle changes you do not expect. 1-on-1 onboarding includes alcohol and lifestyle discussion. 24-hour provider review. Licensed clinicians who look at the full picture. Semaglutide, tirzepatide, NAD+ therapy, and sermorelin. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone currently on semaglutide or tirzepatide who drinks socially. Anyone who has noticed their desire for alcohol decreasing on GLP-1 and wants to understand why. Anyone considering starting GLP-1 medication who wants to know how it will affect their social drinking habits. Anyone concerned about the safety of mixing GLP-1 medications with alcohol.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, lifestyle, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. GLP-1 medications are NOT approved for the treatment of alcohol use disorder. If you are struggling with alcohol addiction, please seek help from an addiction specialist. Always consult your healthcare provider about alcohol use while on any medication. Individual results vary.

#GLP1AndAlcohol #OzempicAlcohol #SemaglutideAlcohol #OzempicMadeMeStopDrinking #GLP1 #Semaglutide #Tirzepatide #WeightLoss #TelehealthFX #TelehealthWeightLoss #AlcoholCravings #DopaminePathway #ClinicalWeightLoss #GLP1SideEffects #OzempicAlternative #WeightLossDelivered #NoHiddenFees #NADTherapy #Sermorelin #AlcoholTolerance #GLP1Research #DrinkingOnOzempic #WeightLossProgram #AlcoholAndWeightLoss

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX offers BOTH semaglutide AND tirzepatide so your provider can recommend the right fit for your body and goals. No hidden membership fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

⚖️ Tirzepatide or semaglutide — which one should you take? In this episode of TelehealthFX Talk, we break down the fundamental mechanism difference between these two medications, walk through the SURMOUNT-5 head-to-head clinical trial results, and help you understand which option may be right for your individual situation.

👇 HERE'S WHAT WE COVER 👇

• The mechanism difference — semaglutide (Wegovy/Ozempic) is a GLP-1 receptor agonist targeting one pathway. Tirzepatide (Zepbound/Mounjaro) is a dual GIP + GLP-1 receptor agonist targeting two pathways simultaneously. The dual action may provide more comprehensive metabolic regulation including enhanced insulin response, improved insulin sensitivity, and improved fat metabolism.

• SURMOUNT-5 head-to-head results (72 weeks):

  - Tirzepatide: -20.2% body weight loss (~50.3 lbs average)

  - Semaglutide: -13.7% body weight loss (~33.1 lbs average)

  - Tirzepatide produced 47% greater relative weight loss

  - Tirzepatide: -18.4 cm waist circumference vs. -13.0 cm semaglutide

  - Tirzepatide showed numerically larger improvements in blood pressure, glycemia, fasting insulin, triglycerides, and cholesterol

  - A higher proportion of tirzepatide patients hit ≥10%, ≥15%, ≥20%, and ≥25% weight loss thresholds

• Side effects comparison — both share similar GI side effect profiles (nausea, vomiting, diarrhea, constipation). Generally mild to moderate during dose escalation. Both carry boxed warning for thyroid C-cell tumors. Both contraindicated with personal/family history of medullary thyroid carcinoma or MEN 2.

• Who semaglutide may be better for — patients wanting the longest track record and most published data, patients prioritizing cardiovascular risk reduction evidence, patients wanting an oral option (oral Wegovy approved Dec 2025), first-time GLP-1 users.

• Who tirzepatide may be better for — patients seeking maximum weight loss, patients with significant insulin resistance, patients who have plateaued on semaglutide, patients whose provider recommends the dual-agonist approach.

• Critical safety note — these medications should NEVER be used together. Take one or the other under clinical guidance.

• FULL COMPARISON TABLE:

  - Semaglutide: GLP-1 only | ~13.7% weight loss | Weekly injection | Oral option available | Longer CV track record

  - Tirzepatide: Dual GIP+GLP-1 | ~20.2% weight loss | Weekly injection | No oral option yet | Newer, emerging CV data

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: The biggest GLP-1 matchup

1:15 — How semaglutide works (GLP-1 only)

2:00 — How tirzepatide works (dual GIP + GLP-1)

2:45 — SURMOUNT-5 head-to-head results

4:00 — The numbers: 20.2% vs. 13.7% weight loss

4:45 — Side effects comparison

5:15 — Who is semaglutide better for?

5:45 — Who is tirzepatide better for?

6:30 — Why having access to BOTH matters

7:15 — Safety: never use together

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

Unlike most platforms that offer only one option, TelehealthFX provides BOTH semaglutide AND tirzepatide. Your licensed provider evaluates your medical history, metabolic profile, and goals to recommend the right medication for you. If you start on one and need to switch, they facilitate the transition under proper clinical guidance. 24-hour provider review. 1-on-1 onboarding. NAD+ therapy and sermorelin. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone trying to decide between semaglutide and tirzepatide. Anyone confused by the brand names (Wegovy, Ozempic, Zepbound, Mounjaro). Anyone currently on semaglutide who has plateaued and is considering switching. Anyone who wants to understand the clinical data before making a decision with their provider.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, telehealth, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. These are prescription medications requiring clinical evaluation. Never use these medications together. Always consult your healthcare provider to determine which is appropriate for your individual situation. Individual results vary.

#TirzepatideVsSemaglutide #Tirzepatide #Semaglutide #Zepbound #Wegovy #Mounjaro #Ozempic #GLP1 #GIP #DualAgonist #SURMOUNT5 #WeightLoss #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #GLP1Comparison #OzempicAlternative #WeightLossDelivered #NoHiddenFees #NADTherapy #Sermorelin #WeightLossForWomen #WeightLossForSeniors #OnlineWeightLoss #WeightLossProgram #GLP1ForWeightLoss

Explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine) — or take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) if you are exploring semaglutide or tirzepatide for PCOS-related weight management. Visit [https://telehealthfx.com](https://telehealthfx.com) for the full range of clinical options including berberine, GLP-1 medications, NAD+ therapy, and sermorelin.

🌿 Does berberine really help with PCOS? In this episode of TelehealthFX Talk, we break down the actual clinical research on berberine for polycystic ovary syndrome — from insulin sensitivity and androgen reduction to weight management and menstrual regularity. We compare berberine to metformin head-to-head, cover critical safety warnings, and give you a complete PCOS management framework.

👇 HERE'S WHAT WE COVER 👇

• What is PCOS? — Polycystic ovary syndrome is a chronic endocrine and metabolic disorder affecting an estimated 10-13% of women of reproductive age globally (WHO). Up to 70-75% of cases are undiagnosed. Common symptoms include irregular periods, hyperandrogenism (acne, hirsutism, hair loss), weight gain, insulin resistance, fatigue, and difficulty conceiving.

• The PCOS vicious cycle — insulin resistance drives excess insulin, which stimulates excess androgens from the ovaries and reduces SHBG (increasing free testosterone). Excess androgens promote visceral fat, which worsens insulin resistance. Understanding this cycle is key to effective treatment.

• Berberine evidence for insulin sensitivity — multiple RCTs and meta-analyses confirm improvement, comparable to metformin.

• Berberine evidence for androgen reduction — meta-analysis shows significant reduction in total testosterone and improved LH/FSH ratio.

• Berberine evidence for weight management — modest reductions in weight, BMI, and waist circumference — clinically meaningful in PCOS where 5-10% loss significantly improves symptoms.

• Berberine evidence for menstrual regularity — some evidence for restored regular cycles and improved ovulation rates.

• Berberine evidence for lipid profiles — may lower LDL and triglycerides while raising HDL, potentially stronger than metformin.

• Berberine vs. metformin comparison — comparable effectiveness for insulin sensitivity and androgen markers. Metformin has a stronger evidence base, better fertility/pregnancy data, and FDA regulation. Berberine may be better tolerated (fewer GI side effects) and may have stronger lipid effects. Critical: discontinue berberine when trying to conceive — insufficient pregnancy safety data.

• Dosage and alternatives — 500 mg taken 2-3 times daily with meals. Dihydroberberine alternative: 100-300 mg/day for up to 5x better absorption.

• Safety warnings — do NOT combine berberine with metformin or other blood sugar medications without provider supervision (hypoglycemia risk). Berberine inhibits CYP3A4 liver enzymes — interacts with many medications. Discontinue before conception.

• PCOS Management Step 1 — Address insulin resistance (berberine, metformin, or GLP-1 per provider).

• PCOS Management Step 2 — Protein priority: 25-30g per meal.

• PCOS Management Step 3 — Resistance training: 2-3x/week for insulin sensitivity.

• PCOS Management Step 4 — Stress management and sleep optimization.

• PCOS Management Step 5 — Clinical team: work with providers that treat PCOS as a metabolic condition.

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: PCOS affects millions

1:00 — What is PCOS? Symptoms and statistics

2:00 — The PCOS vicious cycle: insulin resistance explained

3:00 — Berberine evidence: insulin, androgens, weight

4:15 — Menstrual regularity and lipid improvements

4:45 — Berberine vs. metformin: head-to-head comparison

5:45 — Dosage and dihydroberberine

6:15 — Critical safety warnings

6:45 — Complete PCOS management framework

7:30 — How TelehealthFX helps

7:50 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Explore berberine: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

TelehealthFX offers berberine and GLP-1 medications on a single clinical platform. Providers evaluate whether berberine, semaglutide, tirzepatide, or a combination approach is right for your PCOS management. 24-hour provider review. 1-on-1 onboarding. NAD+ therapy and sermorelin. Transparent pricing. No hidden membership fees. Licensed in all 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Women diagnosed with PCOS looking for evidence-based supplementation options. Women who cannot tolerate metformin and are exploring berberine as an alternative. Anyone who wants to understand the science behind berberine's effects on insulin resistance and androgen levels. Women with PCOS-related weight gain seeking a comprehensive management approach.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, berberine, women's health, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. PCOS is a complex condition — your management plan should be developed with your healthcare provider. If you suspect you have PCOS, seek a proper diagnosis. Do not start or stop any medication or supplement without clinical guidance. Individual results vary.

#BerberineForPCOS #PCOS #PCOSWeightLoss #InsulinResistance #Berberine #BerberineVsMetformin #Hyperandrogenism #TelehealthFX #TelehealthWeightLoss #PCOSManagement #GLP1 #Semaglutide #Tirzepatide #ClinicalWeightLoss #WomensHealth #HormonalHealth #PolycysticOvarySyndrome #BerberineBenefits #PCOSDiet #PCOSSupplements #NoHiddenFees #NADTherapy #Sermorelin #MetabolicHealth #PCOSAwareness #BerberineInsulin #OzempicAlternative #Dihydroberberine

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — see if you are eligible for semaglutide or tirzepatide with clinical support designed for women navigating perimenopause and midlife weight challenges. No hidden membership fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🧬 Why does weight loss get so much harder after 40? In this episode of TelehealthFX Talk, we break down the 5 biological mechanisms that change in women's bodies during perimenopause and menopause — and explain why traditional "eat less, move more" advice stops working. Then we show how GLP-1 medications address these exact challenges and give you a complete midlife weight loss framework.

👇 HERE'S WHAT WE COVER 👇

• The 5 biological drivers that make weight loss harder after 40:

  - Declining estrogen — shifts fat storage from hips/thighs to abdomen ("meno-belly"). Creates visceral fat that wraps around organs and functions as an inflammatory endocrine organ. Disrupts metabolism, hunger signals, and insulin sensitivity.

  - Muscle loss (sarcopenia) — natural age-related muscle decline accelerates after 40. Less muscle = lower resting metabolic rate = easier weight gain even on the same diet.

  - Insulin resistance — estrogen helps maintain insulin sensitivity. As it declines, cells become less responsive to insulin, driving fat storage in the midsection. Visceral fat makes insulin resistance worse, creating a vicious cycle.

  - Cortisol and stress — midlife stress elevates cortisol, which directly promotes visceral fat storage and triggers cravings for comfort foods.

  - Sleep disruption — hot flashes, night sweats, and hormonal shifts wreck sleep quality. Poor sleep disrupts ghrelin and leptin, increasing hunger and reducing satiety.

• How GLP-1 medications address these specific challenges:

  - Appetite suppression counteracts hormonal hunger increases

  - Food noise reduction quiets cortisol-driven cravings

  - Improved insulin sensitivity directly addresses the insulin resistance cycle

  - Visceral fat reduction targets the most metabolically dangerous fat

  - Cardiovascular risk reduction addresses increased heart disease risk after menopause

• The complete midlife weight loss framework:

  - GLP-1 medication — addresses appetite, insulin resistance, visceral fat

  - Protein priority — 25-30g per meal to support muscle maintenance

  - Resistance training — 2-3x/week to counteract sarcopenia and boost metabolism

  - Sleep optimization — 7-9 hours, address hot flashes with provider

  - Stress management — yoga, meditation, breathing exercises to lower cortisol

• Why "eat less, move more" stops working — these are biochemical barriers, not behavioral ones. You cannot out-discipline biology. GLP-1 medications provide the biochemical reset that creates a window for lifestyle changes to actually work.

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: It's not your fault

1:15 — Driver #1: Declining estrogen and meno-belly

2:15 — Driver #2: Muscle loss and metabolic slowdown

2:45 — Driver #3: Insulin resistance — the vicious cycle

3:30 — Drivers #4-5: Cortisol, stress, and sleep disruption

4:15 — Why "eat less, move more" stops working

4:45 — How GLP-1 addresses each biological barrier

5:45 — The complete midlife weight loss framework

6:45 — NAD+ and sermorelin for midlife wellness

7:15 — "You were not failing — the tools were wrong"

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

TelehealthFX provides clinical support that understands the unique challenges women over 40 face. 24-hour provider review evaluates your full hormonal and metabolic picture. 1-on-1 onboarding builds your complete plan. Semaglutide, tirzepatide, NAD+ therapy (combats midlife fatigue), and sermorelin (supports lean mass preservation). Transparent pricing. No hidden membership fees. Licensed in all 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Every woman over 40 who has tried diets and exercise and feels like nothing works anymore. Women in perimenopause or menopause experiencing unexplained weight gain, especially around the midsection. Women who want to understand the biology behind midlife weight gain and learn about evidence-based clinical solutions.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, women's health, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. Please consult with your healthcare provider about your individual health situation, including any menopause-related symptoms. Individual results vary.

#WeightLossOver40 #WomenOver40 #MenopauseWeightLoss #Perimenopause #MenoBelly #GLP1 #Semaglutide #Tirzepatide #TelehealthFX #TelehealthWeightLoss #InsulinResistance #VisceralFat #HormonalWeightGain #ClinicalWeightLoss #WeightManagement #GLP1ForWeightLoss #WeightLossForWomen #OzempicAlternative #NoHiddenFees #NADTherapy #Sermorelin #MidlifeHealth #WomensHealth #Sarcopenia #CortisolAndWeight #MenopauseHelp #WeightLossProgram

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — see if you are eligible for semaglutide or tirzepatide with 1-on-1 onboarding that includes fitness and lifestyle guidance. No hidden membership fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🏋️‍♀️ Are you exercising the right way on your GLP-1 medication? In this episode of TelehealthFX Talk, we break down exactly how to combine semaglutide or tirzepatide with exercise to maximize your results and protect your muscle mass. We cover the two pillars of exercise that matter most, how to time workouts around injections, what to do when you are low on energy, and a complete no-gym-required weekly plan you can start today.

👇 HERE'S WHAT WE COVER 👇

• Why exercise matters more on GLP-1 — medications create a caloric deficit through appetite suppression. Without exercise, a significant portion of weight lost will be muscle, not just fat. Exercise determines the quality of your weight loss.

• Pillar 1: Resistance training (the non-negotiable) — 2-3 sessions per week targeting all major muscle groups. Provides the mechanical stimulus that tells your body to preserve muscle tissue during weight loss. No gym required — bodyweight exercises (squats, push-ups, lunges, planks) and resistance bands work. Focus on progressive overload for consistent improvement.

• Pillar 2: Cardiovascular exercise (the complement) — at least 150 minutes per week of moderate-intensity aerobic activity (walking, cycling, swimming, dancing). Supports heart health, metabolic function, and mood. Important note: cardio alone does NOT prevent muscle loss — it must be combined with resistance training.

• Timing around injections — side effects typically peak 24-48 hours post-injection. Schedule lighter workouts on injection day and the day after. Save harder sessions for mid-week when you feel your best.

• Timing around meals — GLP-1 slows gastric emptying, so wait 2-4 hours after eating before exercising. Many patients prefer fasted morning workouts. If feeling dizzy, have a small easily digestible snack.

• Managing low energy — break 30-minute sessions into three 10-minute walks. Light walking can alleviate mild nausea. Small carb snacks before workouts help. Prioritize 7-9 hours of sleep.

• Hydration — GLP-1 increases dehydration risk, amplified by exercise. Drink water consistently throughout the day. Pale yellow urine = properly hydrated.

• Hypoglycemia safety — GLP-1 + exercise both lower blood sugar. Keep fast-acting carbs (glucose tablets, juice) on hand. Stop immediately if dizzy, shaky, or confused.

• Sample weekly plan (no gym required):

  - Monday: 30-min bodyweight resistance (squats, push-ups, lunges, planks)

  - Tuesday: 30-min brisk walk

  - Wednesday: 30-min resistance training

  - Thursday: Rest or 20-min gentle yoga/stretching

  - Friday: 30-min resistance training

  - Saturday: 30-45 min walk or cycling

  - Sunday: Rest

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: Medication + exercise = better results

1:30 — The fundamental principle: exercise determines what you lose

2:15 — Pillar 1: Resistance training explained

3:30 — Pillar 2: Cardio as the complement

4:15 — Timing around injections and meals

5:15 — Low energy days: practical solutions

6:00 — Hydration and safety precautions

6:30 — Your sample weekly plan (no gym needed)

7:15 — NAD+ and sermorelin for recovery

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

TelehealthFX's 1-on-1 onboarding includes fitness and lifestyle guidance, not just a prescription. Semaglutide, tirzepatide, NAD+ therapy (supports cellular energy and recovery), and sermorelin (supports lean mass preservation). Comprehensive approach. Transparent pricing. No hidden membership fees. 24-hour provider review. 2-day UPS shipping. Licensed in all 50 states.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone currently on semaglutide or tirzepatide who wants to maximize their results with exercise. Anyone about to start GLP-1 medication who wants to build the right fitness foundation from day one. Anyone on GLP-1 who is only doing cardio and not seeing the body composition changes they expected.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, fitness, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice or a personalized exercise prescription. Always consult your healthcare provider before starting any new exercise program, especially if you have existing health conditions. Individual results vary.

#GLP1Exercise #SemaglutideWorkout #GLP1AndExercise #ResistanceTraining #WeightLoss #TelehealthFX #Semaglutide #Tirzepatide #GLP1 #TelehealthWeightLoss #OzempicExercise #ClinicalWeightLoss #WeightManagement #MusclePreservation #GLP1ForWeightLoss #WeightLossDelivered #NoHiddenFees #NADTherapy #Sermorelin #BodyweightWorkout #NoGymNeeded #ProgressiveOverload #WeightLossForWomen #WeightLossForSeniors #OzempicAlternative #WeightLossProgram